Glaucoma screening: where are we and where do we need to go?

Journal: Current opinion in ophthalmology
Published Date:

Abstract

PURPOSE OF REVIEW: Current recommendations for glaucoma screening are decidedly neutral. No studies have yet documented improved long-term outcomes for individuals who undergo glaucoma screening versus those who do not. Given the long duration that would be required to detect a benefit, future studies that may answer this question definitively are unlikely. Nevertheless, advances in artificial intelligence and telemedicine will lead to more effective screening at lower cost. With these new technologies, additional research is needed to determine the costs and benefits of screening for glaucoma.

Authors

  • Nicholas Y Q Tan
    Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.
  • David S Friedman
    Massachusetts Eye and Ear Infirmary.
  • Ingeborg Stalmans
    Research Group Ophthalmology, KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.
  • Iqbal Ike K Ahmed
    Department of Ophthalmology, University of Toronto, Toronto, Ontario, Canada.
  • Chelvin C A Sng
    Singapore Eye Research Institute, Singapore.